Literature DB >> 9107398

Congenital orbital teratoma.

G A Lee1, T J Sullivan, G P Tsikleas, N G Davis.   

Abstract

BACKGROUND: The occurrence of proptosis at birth is unusual and may be associated with a variety of tumours and structural abnormalities. Congenital orbital teratoma is a rare cause of congenital proptosis.
METHODS: A case report is presented of a female infant with gross right proptosis.
RESULTS: Computed tomography demonstrated a characteristic multicystic structure with no intracranial involvement. Histological examination found tissues derived from all three germ cell layers, consistent with a congenita orbital teratoma. The tumour was successfully removed preserving the globe and vision.
CONCLUSIONS: This report is an example of how early surgical intervention may allow preservation of the globe and vision in some patients with congenital orbital teratoma.

Entities:  

Mesh:

Year:  1997        PMID: 9107398     DOI: 10.1111/j.1442-9071.1997.tb01277.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  4 in total

1.  Restoration of cardiopulmonary function with 21% versus 100% oxygen after hypoxaemia in newborn pigs.

Authors:  D Fugelseth; W B Børke; K Lenes; I Matthews; O D Saugstad; E Thaulow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

2.  Prenatal Exophthalmia Revealing a Postnatal Orbital Teratoma.

Authors:  Ahgbatouhabeba Ahnoux-Zabsonre; Jérôme Sanou; Yérénou Ferdinand Lankoandé; Chantal Bouda; Gertrude Méda; Assita Lamien-Sanou
Journal:  Case Rep Ophthalmol Med       Date:  2020-07-13

3.  Mature teratoma presenting as orbital cellulitis in a 5-month-old baby.

Authors:  Hind Manaa Alkatan; Imtiaz Chaudhry; Ayman Alayoubi
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

4.  Congenital orbital teratoma: a case report with preservation of the globe and 18 years of follow-up.

Authors:  Panagiotis A Tsoutsanis; George C Charonis
Journal:  BMC Ophthalmol       Date:  2021-12-28       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.